Compounds > fluorodopa f 18
Page last updated: 2024-08-24

fluorodopa f 18 and Carcinoma, Medullary

fluorodopa f 18 has been researched along with Carcinoma, Medullary in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anner, P; Dudczak, R; Haug, A; Karanikas, G; Mayerhoefer, M; Sesti, A; Wadsak, W; Weber, M1
Dollé, F; Ducongé, F; Gombert, K; Kuhnast, B; Le Helleix, S; Pestourie, C; Tavitian, B; Thézé, B1
Ambrosini, V; Fanti, S; Marzola, MC; Rubello, D1
Al-Nahhas, A; Ambrosini, V; Fanti, S; Ferdeghini, M; Gross, MD; Marzola, MC; Massaro, A; Pelizzo, MR; Rubello, D; Toniato, A1
Buck, AK; Dralle, H; Glatting, G; Karges, W; Luster, M; Mottaghy, FM; Neumaier, B; Pauls, S; Reske, SN; Solbach, C; Verburg, FA; Zeich, K1
Grahek, D; Kerrou, K; Montravers, F; Nataf, V; Pascal, O; Soussan, M; Talbot, JN1
Beuthien-Baumann, B; Bredow, J; Kotzerke, J; Strumpf, A; Zessin, J1
Altehoefer, C; Brink, I; Ghanem, N; Hoegerle, S; Moser, E; Nitzsche, E1

Trials

1 trial(s) available for fluorodopa f 18 and Carcinoma, Medullary

ArticleYear
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:1

    Topics: Aged; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed

2001

Other Studies

7 other study(ies) available for fluorodopa f 18 and Carcinoma, Medullary

ArticleYear
Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET.
    Anticancer research, 2014, Volume: 34, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography

2014
PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[(18)F]F-L-DOPA.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:1

    Topics: Animals; Carcinoma, Medullary; Dihydroxyphenylalanine; Mice; Mice, Transgenic; Multiple Endocrine Neoplasia Type 2a; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms

2010
(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:1

    Topics: Carcinoma, Medullary; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Somatostatin; Thyroid Gland; Thyroid Neoplasms

2010
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2010, Volume: 36, Issue:4

    Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy

2010
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:5

    Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Medullary; Child; Dihydroxyphenylalanine; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Young Adult

2010
Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer.
    Nuclear medicine communications, 2012, Volume: 33, Issue:7

    Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed

2012
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:10

    Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms

2007